Havn Life
CSE: HAVN | OTC: HAVNLF
HAVN Life Sciences is a biotechnology company focused on standardized, quality-controlled extraction of psychoactive compounds from plants and fungi, and the development of natural health care products from non-regulated compounds. They went public in September 2020.
[mstock id="2982"]
[mstock id="2983"]
There is a tremendous opportunity to transform and enhance the healthcare and wellness space with psychedelic medicine, and the time is now to lay the foundations for what is likely to be a significant industry. Our multidisciplinary team is focused on laying the groundwork by developing quality controls and methodology for research and the medical supply chain.
